Juglanthraquinone C (JC)， a naturally occurring anthraquinone extracted from Juglans mandshurica， could induce apoptosis of cancer cells. This study aims to investigate the detailed cytotoxicity mechanism of JC in HepG2 and BEL-7402 cells. The Affymetrix HG-U133 Plus 2.0 arrays were first used to analyze the mRNA expression exposed to JC or DMSO in HepG2 cells. Consistent with the previous results， the data indicated that JC could induce apoptosis and hyperactivated Akt. The Western blot analysis further revealed that Akt， a well-known survival protein， was strongly activated in HepG2 and BEL-7402 cells. Furthermore， an obvious inhibitory effect on JC-induced apoptosis was observed when the Akt leve... More
Juglanthraquinone C (JC)， a naturally occurring anthraquinone extracted from Juglans mandshurica， could induce apoptosis of cancer cells. This study aims to investigate the detailed cytotoxicity mechanism of JC in HepG2 and BEL-7402 cells. The Affymetrix HG-U133 Plus 2.0 arrays were first used to analyze the mRNA expression exposed to JC or DMSO in HepG2 cells. Consistent with the previous results， the data indicated that JC could induce apoptosis and hyperactivated Akt. The Western blot analysis further revealed that Akt， a well-known survival protein， was strongly activated in HepG2 and BEL-7402 cells. Furthermore， an obvious inhibitory effect on JC-induced apoptosis was observed when the Akt levels were decreased， while the overexpression of constitutively active mutant Akt greatly accelerated JC-induced apoptosis. The subsequent results suggested that JC treatment suppressed nuclear localization and increased phosphorylated levels of Foxo3a， and the overexpression of Foxo3a abrogated JC-induced apoptosis. Most importantly， the inactivation of Foxo3a induced by JC further led to an increase of intracellular ROS levels by suppressing ROS scavenging enzymes， and the antioxidant N-acetyl-L-cysteine and catalase successfully decreased JC-induced apoptosis. Collectively， this study demonstrated that JC induced the apoptosis of hepatocellular carcinoma (HCC) cells by activating Akt/Foxo signaling pathway and increasing intracellular ROS levels.
